Moneta Group Investment Advisors’s Biogen BIIB Stock Holding History

Moneta Group Investment Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$231K	Buy	+1,069	New	+$204K	﹤0.01%	786
2024 Q4	–	Sell	-1,291	Closed	-$250K	–	668
2024 Q3	$250K	Buy	+1,291	New	+$270K	﹤0.01%	564
2021 Q2	–	Sell	-1,659	Closed	-$464K	–	451
2021 Q1	$464K	Buy	+1,659	New	+$447K	0.02%	271
2020 Q2	–	Sell	-670	Closed	-$212K	–	253
2020 Q1	$212K	Buy	+670	New	+$203K	0.02%	219
2018 Q3	–	Sell	-1,023	Closed	-$297K	–	247
2018 Q2	$297K	Buy	1,023 +53	+5%	+$14.9K	0.03%	210
2018 Q1	$266K	Buy	970 +287	+42%	+$89.1K	0.04%	167
2017 Q4	$218K	Sell	683 -20	-3%	-$6.42K	0.03%	184
2017 Q3	$220K	Buy	+703	New	+$208K	0.03%	187
2015 Q4	–	Sell	-54	Closed	-$16K	–	165
2015 Q3	$16K	Buy	+54	New	+$17.8K	﹤0.01%	352

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Moneta Group Investment Advisors's BIIB Position: Q2 2026 in Review

Moneta Group Investment Advisors opened a new position in Biogen (BIIB) in Q2 2026: 1,069 shares worth $231K. The stake represents ﹤0.01% of the portfolio and ranks #786 among its holdings. This is a return to the name: Moneta Group Investment Advisors previously reported a position in BIIB as recently as Q3 2024.

Moneta Group Investment Advisors first reported a position in BIIB in Q3 2015 and has held it in 9 quarters since. The position peaked at $464K in Q1 2021. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

Moneta Group Investment Advisors held 1,069 shares of Biogen worth $231K as of Q2 2026.
Biogen was a new Moneta Group Investment Advisors position in Q2 2026.
Biogen made up ﹤0.01% of Moneta Group Investment Advisors's portfolio in Q2 2026, its #786 holding.
Moneta Group Investment Advisors first reported a position in Biogen in Q3 2015 and has held it in 9 quarters since.
Moneta Group Investment Advisors's Biogen position peaked at $464K in Q1 2021.
1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Moneta Group Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.